These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1313163)

  • 1. [Chronic use of glucomannan in the dietary treatment of severe obesity].
    Vita PM; Restelli A; Caspani P; Klinger R
    Minerva Med; 1992 Mar; 83(3):135-9. PubMed ID: 1313163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].
    Cairella M; Marchini G
    Clin Ter; 1995 Apr; 146(4):269-74. PubMed ID: 7796558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucomannan on obese patients: a clinical study.
    Walsh DE; Yaghoubian V; Behforooz A
    Int J Obes; 1984; 8(4):289-93. PubMed ID: 6096282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.
    Salas-Salvadó J; Farrés X; Luque X; Narejos S; Borrell M; Basora J; Anguera A; Torres F; Bulló M; Balanza R;
    Br J Nutr; 2008 Jun; 99(6):1380-7. PubMed ID: 18031592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of highly purified glucomannan-based fibers in childhood obesity].
    Livieri C; Novazi F; Lorini R
    Pediatr Med Chir; 1992; 14(2):195-8. PubMed ID: 1324483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults.
    Keithley JK; Swanson B; Mikolaitis SL; DeMeo M; Zeller JM; Fogg L; Adamji J
    J Obes; 2013; 2013():610908. PubMed ID: 24490058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with three different fiber supplements in weight reduction.
    Birketvedt GS; Shimshi M; Erling T; Florholmen J
    Med Sci Monit; 2005 Jan; 11(1):PI5-8. PubMed ID: 15614200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of supplements of partially hydrolyzed guar gum on the occurrence of constipation and use of laxative agents.
    Patrick PG; Gohman SM; Marx SC; DeLegge MH; Greenberg NA
    J Am Diet Assoc; 1998 Aug; 98(8):912-4. PubMed ID: 9710664
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucomannan and obesity: a critical review.
    Keithley J; Swanson B
    Altern Ther Health Med; 2005; 11(6):30-4. PubMed ID: 16320857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb].
    Fanelli V; Angelico F; Stefanutti C; Calvieri A; Fazio S
    Clin Ter; 1986 Oct; 119(1):17-23. PubMed ID: 3024902
    [No Abstract]   [Full Text] [Related]  

  • 11. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo.
    Vido L; Facchin P; Antonello I; Gobber D; Rigon F
    Padiatr Padol; 1993; 28(5):133-6. PubMed ID: 8247594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocholesterolemic effect of guargum in overweight adults.
    Kawatra A; Kapoor AC; Seghal S
    Plant Foods Hum Nutr; 1991 Jul; 41(3):241-5. PubMed ID: 1656425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Med Clin (Barc); 2013 Sep; 141(5):189-93. PubMed ID: 23601741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.
    Papi C; Ciaco A; Koch M; Capurso L
    Ital J Gastroenterol; 1992 Oct; 24(8):452-6. PubMed ID: 1330083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials.
    Onakpoya I; Posadzki P; Ernst E
    J Am Coll Nutr; 2014; 33(1):70-8. PubMed ID: 24533610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-fibre bean-rich diet versus a low-carbohydrate diet for obesity.
    Tonstad S; Malik N; Haddad E
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():109-16. PubMed ID: 23627924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children.
    Staiano A; Simeone D; Del Giudice E; Miele E; Tozzi A; Toraldo C
    J Pediatr; 2000 Jan; 136(1):41-5. PubMed ID: 10636972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy].
    Signorelli P; Croce P; Dedè A
    Minerva Ginecol; 1996 Dec; 48(12):577-82. PubMed ID: 9026754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-loss with low or high carbohydrate diet?
    Golay A; Eigenheer C; Morel Y; Kujawski P; Lehmann T; de Tonnac N
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1067-72. PubMed ID: 8968851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.